JAMA Dermatology · 2014 · 18 citations · 3 references
MedicinePharmacotherapyPhysiologyCardiovascular PharmacotherapyInflammationVascular SurgeryEndothelial ActivationEndothelial DysfunctionLymphatic PhysiologyLymphatic RemodelingMuscle TissueVasoactive MedicationsEndothelial Cell PhysiologyIndirect EffectsLymphangiogenesisNitric OxideNitric Oxide Synthase RegulationNitric Oxide-mediated VasodilationSmooth Muscle LayerVascular Smooth Muscle Relaxation
Another possible explanation includes induction of nitric oxide synthase by sildenafil, stimulating further cGMP-mediated vasodilation, 5 permitting lymphatic dilatation and enhanced lymphatic drainage; endothelial nitric oxide synthase has also been shown to mediate lymphangiogenesis. 6 Novel effects of sildenafil on LM tissue should also be considered.A lack of PDE5 expression in LM endothelium in our study suggests that sildenafil is likely to produce decompression of LM via indirect effects on adjacent smooth muscle.We propose that sildenafil may mediate relaxation of perivascular smooth muscle in LM tissue, allowing decompression of dilated lymphatic spaces; additional studies to elucidate specific physiologic effects of sildenafil in LM are warranted.
3
Giant acquired digital fibrokeratoma
Maki Kakurai, Tomoko Yamada, Tomoharu Kiyosawa et al. · Journal of the American Academy of Dermatology · 2003 · 37 citations
Medicine, Dermatology, Pathology +8
ACQUIRED PERIUNGUAL FIBROKERATOMA
Yoshihiro Yasuki · The Journal of Dermatology · 1985 · 34 citations
Medicine, Dermatology, Pathology +7